QIM
ACHN

Quantitative Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Quantitative Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-236,634
Closed -$851K – 846
2019
Q3 		$851K Buy
+236,634
New +$912K 0.05% 381
2016
Q3 		– Sell
-97,900
Closed -$763K – 939
2016
Q2 		$763K Buy
+97,900
New +$840K 0.04% 477
2016
Q1 		– Sell
-39,900
Closed -$430K – 1005
2015
Q4 		$430K Buy
39,900
+19,200
+93% +$175K 0.03% 527
2015
Q3 		$143K Buy
+20,700
New +$169K 0.01% 628
2015
Q2 		– Sell
-19,500
Closed -$192K – 757
2015
Q1 		$192K Buy
+19,500
New +$243K 0.02% 571
2014
Q4 		– Sell
-63,300
Closed -$631K – 620
2014
Q3 		$631K Sell
63,300
-21,800
-26% -$202K 0.12% 146
2014
Q2 		$644K Buy
+85,100
New +$340K 0.12% 192

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantitative Investment Management's ACHN Position: Q4 2019 in Review

Quantitative Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 236,634 shares — an estimated $851K sold.

Quantitative Investment Management first reported a position in ACHN in Q2 2014 and held it in 7 quarters. The position peaked at $851K in Q3 2019. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Quantitative Investment Management reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 236,634 Achillion Pharmaceuticals shares in Q4 2019, an estimated $851K.
  • Quantitative Investment Management first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 7 quarters.
  • Quantitative Investment Management's Achillion Pharmaceuticals position peaked at $851K in Q3 2019.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Quantitative Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.